TEL-AVIV, Israel and VANCOUVER, Washington, October 17, 2011 /PRNewswire/ --
Results from a study validating Cheetah Medical's non-invasive NICOM system for use in surgery to guide fluid management were presented October 16 at the 2011 American Society of Anesthesiologists Annual Meeting in Chicago. This new study complements a strong body of evidence that demonstrates that when anesthesiologists base delivery of intravenous fluids on repetitive measurements of cardiac output, they are able to significantly reduce a host of complications associated with surgery and the length of hospital stay. This guided approach to deliver fluids is known as Goal Directed Therapy (GDT).
The Cheetah NICOM has been validated to provide highly accurate continuous hemodynamic information that can be reliably used to guide fluid management and support GDT. In this study, Duke Anesthesia researchers used Cheetah Medical's non-invasive NICOM® cardiac output & hemodynamic monitoring system alongside the invasive legacy transesophageal Doppler. Study investigators compared readings obtained with the legacy system to the NICOM in 61 patients as they underwent major surgery and found a consistent and significant correlation between both devices' readings and directions on fluid management. In addition, results indicated that the invasive Doppler device was twice as likely to fail to provide readings during the case for technical reasons as compared to the non-invasive NICOM.
"The results from this study add to a large body of evidence showing that perioperative Goal Directed Therapy using non-invasive hemodynamic monitors should be considered in patients undergoing major surgery or in high risk patients. This strategy improves patient outcomes and reduces length of hospital stay," said Tong J. Gan, MD Professor of Anesthesiology and Vice Chair for Clinical Research at Duke University Medical Center and the study's Principal Investigator.
|SOURCE Cheetah Medical Ltd|
Copyright©2010 PR Newswire.
All rights reserved